HIV Slides 1-13: Intro Flashcards

1
Q

How do retroviruses work?

A

Reverse transcriptase integrates viral RNA into host DNA - stays forever

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What do viral oncogenes do?

A

Transform the host cell to express oncogenes, growth factors. Malignant transformation occurs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What do host proto-oncogenes do?

A

Host non active genes that viral DNA activates to transform cells.
Leukemia or sarcoma viruses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is HTLV1

A

Human T-cell leukemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is HTLV2?

A

Hairy T-cell leukemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the origin of HIV?

A

Cross-species transmission of Simian Immunodeficiency virus (SIV)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How does HIV infect the cells?

A

Binds CD4 receptor on human t-lymphocytes (gp 120 and gp 41 on virus)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What proteins does the HIV virus code for?

A

Reverse transcriptase, integrase, and protease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What do viral encoded proteases do?

A

Cleave functional viral proteins from precursors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How many new virions are produced each day?

A

10^9

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Infected T-cells have a half life of?

A

1.6 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Time from release of new virion to infection of a new cell and release of another new virion is?

A

2.6 days

140 generations of virus each year

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the goals of therapy for HIV?

A

Maximal and durable suppression of viral load (HIV RNA less than 50 copies per mL)

Reduction of HIV-related morbidity and mortality

Improvement of quality of life

Restoration of immunologic function

Prevent HIV transmission

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What treatment considerations are there for HIV?

A

Resistance (6-16% to at least one drug class)
Tropism (CCR5 or CXCR4)
Contraindications (CD4 count/HLA typing)
Co-morbidities (Hepatitis)
Adherence potential (greater than 95%) - dosing frequency, number, size of pills, cost, food and fluid restrictions
Adverse drug reactions (Potential drug interactions and pregnancy)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

In the first 2-4 weeks, what occurs to CD4+ cell count?

A

It decreases, then increases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

In the first 6-10 years, what happens to CD4+ cell count?

A

It continues to decrease

17
Q

In the last 2-3 years of HIV, what happens to CD4+ cell counts?

A

It continues to decrease

18
Q

In the first 2-4 weeks, what happens to virus levels in the blood?

A

They increase to a peak, causing flu like symptoms

19
Q

In the first 6-10 years, what happens to virus levels in the blood?

A

They decrease but stay at steady levels

20
Q

In the last 2-3 years, what happens to virus levels in the blood?

A

They start to increase again,

21
Q

What happens to anti-HIV antibody in the first 2-4 weeks?

A

They begin to increase when the HIV virus levels spike

22
Q

What happens to anti-HIV antibody in the first 6-10 years?

A

They increase to a peak and stay steady

23
Q

What happens to anti-HIV antibody in the last 2-3 years?

A

They start to decrease as virus levels increase

First skin and mucous membrane immune defects occur, then systemic immune deficiency

24
Q

When do we treat HIV patients?

A

All HIV infected individuals should be treated regardless of CD4 count to reduce morbidity and mortality from HIV infections and prevent transmission by infected individuals.

25
What groups of patients require special attention with HIV treatment/
Pregnant women Patients with HIV associated nephropathy, HIV associated dementia, or malignancies Patients co-infected with HBV or HBC when treatment is indicated
26
All patients treated for HIV should receive what?
Genotypic drug resistance HLA-B 5701 testing (hypersensitivity reaction with Abacavir) Co-receptor tropism testing (prior to Maraviroc use; CCR5 changes to CXCR4 or mixed tropic with decreased CD 4 counts) Plasma viral RNA load (at baseline and regular basis thereafter esp after changes in therapy)
27
What are the general treatment guidelines for HIV?
Two nucleoside reverse transcriptase inhibitors plus ONE of the following groups: Non nucleoside reverse transcriptase inhibitor (2 NRTI + 1 NNRTI) Protease inhibitor (boosted with Ritonavir) (2 NRTI + 1-2 PI) Integrase stand transfer inhibitor based (2 NRTI + INSTI)